HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James L Goodson Selected Research

Measles

1/2022Innovations in vaccine delivery: increasing access, coverage, and equity and lessons learnt from measles and rubella elimination.
1/2021Development of a Measles and Rubella Multiplex Bead Serological Assay for Assessing Population Immunity.
1/2021Measles in the 21st Century: Progress Toward Achieving and Sustaining Elimination.
11/2020Progress Toward Regional Measles Elimination - Worldwide, 2000-2019.
4/2020Progress Toward Measles Elimination - Eastern Mediterranean Region, 2013-2019.
12/2019Progress Toward Regional Measles Elimination - Worldwide, 2000-2018.
12/2019Progress Toward Measles Elimination - China, January 2013-June 2019.
10/2019Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
7/2019Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.
6/2019Progress Toward Measles Elimination - Pakistan, 2000-2018.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James L Goodson Research Topics

Disease

45Measles
01/2022 - 03/2010
13Rubella (German Measles)
01/2022 - 07/2012
3Poliomyelitis (Polio)
12/2017 - 05/2013
2Congenital Rubella Syndrome (Syndrome, Congenital Rubella)
05/2019 - 08/2016
1Exanthema (Rash)
05/2017
1Meningococcal Meningitis
03/2015
1Paralysis (Palsy)
05/2011
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
11/2004

Drug/Important Bio-Agent (IBA)

40VaccinesIBA
01/2022 - 07/2011
5Indicators and Reagents (Reagents)IBA
11/2020 - 03/2016
4Rubella VaccineIBA
01/2022 - 08/2016
4Measles VaccineIBA
12/2019 - 07/2012
3Immunoglobulin G (IgG)IBA
01/2021 - 08/2016
3Vitamin A (Retinol)FDA LinkGeneric
04/2020 - 03/2010
2Neutralizing AntibodiesIBA
01/2018 - 09/2015
1AntigensIBA
01/2021
1ImmunosorbentsIBA
01/2021
1EnzymesIBA
01/2021
1NucleoproteinsIBA
01/2021
1NucleotidesIBA
07/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1Conjugate VaccinesIBA
03/2015
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
12/2014
1Complement System Proteins (Complement)IBA
04/2014
1Combined VaccinesIBA
05/2013
1Oral Poliovirus Vaccine (Sabin Vaccine)IBA
05/2011
1Mebendazole (Anti-Worm)FDA Link
03/2010
11-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA
11/2004

Therapy/Procedure

2Subcutaneous Injections
12/2016 - 09/2015
1Insecticide-Treated Bednets
04/2012
1Cannula
11/2004